Company Overview and News

26
Going against a global trend, Japan lags on boardroom diversity: study

2018-09-12 japantimes.co.jp
BANGKOK/SINGAPORE – The “old boys club” in the boardroom is alive and well — and most prevalent among the biggest Japanese and Chinese companies.
BCS BNPQY PPRUY SFTBF 83SF SCGLF 83SK PPRUF GM SFTBY 47MC FP STT SCGLY BNPQF BNPZY BABA KER 0700 GLE 9984

3
Barclays joins BNP, HSBC in flurry of yen bank bond deals

2018-09-12 thestar.com.my - 1
TOKYO: Barclays Plc became the latest European bank to kick off a yen bond deal after HSBC Holdings Plc and BNP Paribas SA tapped yen investors in the past month for low-cost funding.
NMR BCS BNPQY BNPQF HCS HSB 0005 83SF BNPZY 83SK 8604 N33 NRSCF HSEA HSEB HSBC HBCYF 47MC

2
Vectura Group plc: Interim Results

2018-09-11 globenewswire
Chippenham, UK - 11 September 2018: Vectura Group plc (LSE: VEC) ("Vectura" or "the Group") announces its unaudited Interim Results for the six months ended 30 June 2018 and reiterates its current guidance for the full year.
11IE BCS OIL 42KM SNY 83SF VEC 83SK GCVRZ 42MA SAN SNYNF VEGPF 47MC

 
ProPhotonix Limited Announces Interim Results

2018-09-07 accesswire
- The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.
83SF BCS OIL 83SK STKR 47MC

26
Men-only corporate boardrooms alive and well in China, Japan

2018-09-07 theedgemarkets
(Sept 7): The “old boys club” in the boardroom is alive and well — and most prevalent among the biggest Japanese and Chinese companies.
BCS BNPQY PPRUY SFTBF 83SF SCGLF 83SK PPRUF GM SFTBY 47MC FP STT SCGLY BNPQF BNPZY BABA KER 0700 GLE 9984

26
Men-only corporate boardrooms alive and well in China, Japan

2018-09-07 livemint
The “old boys club” in the boardroom is alive and well—and most prevalent among the biggest Japanese and Chinese companies.
BCS BNPQY PPRUY SFTBF 83SF SCGLF 83SK PPRUF GM SFTBY 47MC FP STT SCGLY BNPQF BNPZY BABA KER 0700 GLE 9984

1
Barclays doesn’t foresee market collapse if Trump faces impeachment

2018-09-06 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
83SF BCS 83SK 47MC

158
Tracking Chase Coleman's Tiger Global Portfolio - Q2 2018 Update

2018-09-05 seekingalpha - 6
The largest three positions are Spotify, Amazon.com, and JD.com, and they add up to ~30% of the portfolio.
RDFN BCS NOW HUYA REDU FPI CRM QSR.WI SOGO 83SF FEYE AMZN 83SK TWTR MELI SWCH TEAM PSTG COUP BILI CLDR MSFT JD FB FIT LC MDB DOCU NFLX APO ADBE DESP DBX OKTA QSR 47MC SHOP NETS TDG RUN ZTO MA PVTL AVLR V BKNG IQ ADSK FLT

1
Fastest-Growing Major Economy Holds Shaky Crown as Risks Build

2018-09-02 theedgemarkets
(Sept 3): India’s world-beating economic growth is running up against some big risks: high oil prices, emerging market stress as the era of easy money draws to a close, and policy paralysis in the run-up to next year’s federal election.
NMR BCS OIL HCS HSB 0005 83SF 8604 83SK N33 NRSCF HSEA HSEB HSBC HBCYF 47MC

1
Fastest-growing major emerging market holds shaky crown as risks mount

2018-09-02 bworldonline
MUMBAI/NEW DELHI — India’s world-beating economic growth is running up against some big risks: high oil prices, emerging market stress as the era of easy money draws to a close, and policy paralysis in the run-up to next year’s federal election.
NMR BCS OIL HCS HSB 0005 83SF 8604 83SK N33 NRSCF HSEA HSEB HSBC HBCYF 47MC

4
Federal Reserve gives Deutsche Bank, others extension on 'living will' submissions

2018-08-30 reuters
WASHINGTON (Reuters) - The Federal Reserve said on Thursday that it was giving Deutsche Bank AG (DBKGn.DE) and four other financial institutions an additional year to submit “living wills” detailing how they could be safely dissolved in a crisis.
BCS DB DGLD CS 83SF UGLD 83SK 47MC PRU DSLV VIIX CSSLF VIIZ PFK CSGKF PRH ZIV USLV TVIX PJH XIV

10
Big banks win dismissal in US of bond rigging lawsuit

2018-08-29 channelnewsasia
A U.S. judge has dismissed an antitrust lawsuit by investors that accused nine big banks of rigging the roughly US$9 trillion government agency bond market from 2005 to 2015.
BCS BNPQY HSB 83SF UGLD 83SK 8604 DSLV CSSLF HCS BNPZY N33 CGBBW NMR DB DGLD CS TD NRSCF ACA TD HSBC HBCYF 47MC TNTTF C VIIX VIIZ BNPQF CRARF 0005 CSGKF HSEA HSEB ZIV USLV CRARY TVIX XIV

10
Big banks win dismissal in U.S. of bond rigging lawsuit

2018-08-29 reuters
NEW YORK (Reuters) - A U.S. judge has dismissed an antitrust lawsuit by investors that accused nine big banks of rigging the roughly $9 trillion government agency bond market from 2005 to 2015.
BCS BNPQY HSB 83SF UGLD 83SK 8604 DSLV CSSLF HCS BNPZY N33 CGBBW NMR DB DGLD CS TD NRSCF ACA TD HSBC HBCYF 47MC TNTTF C VIIX VIIZ BNPQF CRARF 0005 CSGKF HSEA HSEB ZIV USLV CRARY TVIX XIV

21
Here’s What Blockchain Technology Means for IBM Stock

2018-08-28 investorplace
IBM (NYSE:IBM) has been in a prolonged restructuring, and the results have been mixed at best. This is particularly aggravating since various other old-line tech giants like Microsoft (NASDAQ:MSFT), Cisco (NASDAQ:CSCO) and Adobe (NASDAQ:ADBE), have staged strong turnarounds. But I think investors should not give up on IBM stock.
IBM BCS C CSCO MSFT INTC ORCL ADBE

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to BCS / Barclays Bank Plc on message board site Silicon Investor.

GAAY - Triangle Broadcasting Company (was TBCS) GAAY - Triangle Broadcasting Company (was TBCS) GAAY - Triangle Broadcasting Company (was TBCS) IBCS - International Broadcasting Corporation IBCS - International Broadcasting Corporation IBCS - International Broadcasting Corporation
BCSC/VSE INVESTIGATIONS BCSC/VSE INVESTIGATIONS BCSC/VSE INVESTIGATIONS Global Casinos In. (GBCS) Global Casinos In. (GBCS) Global Casinos In. (GBCS)
CUSIP: 06738E204